Enjoy complimentary customisation on priority with our Enterprise License!
The umbilical vessel catheters market size is forecast to increase by USD 852.6 million, at a CAGR of 10.03% between 2023 and 2028. The market's expansion is significantly influenced by several key factors. The rising incidence of preterm births drives demand for specialized neonatal care and medical products tailored to premature infants. This growing need is further supported by the expansion of neonatal care centers, which are increasingly equipped to provide advanced treatments and care. Additionally, market growth is bolstered by the increasing penetration of healthcare services in emerging economies, where improving maternal and infant health is a priority. As these regions invest in healthcare infrastructure and neonatal care, there is a notable rise in demand for products and services addressing preterm birth challenges. Together, these trends contribute to a dynamic market environment focused on enhancing outcomes for premature infants globally.
For More Highlights About this Report, Request Free Sample
The market is witnessing significant growth due to the increasing number of neonatal care cases, particularly premature births. According to the World Health Organization, approximately 15 million babies are born prematurely each year. Umbilical vessel catheters are essential in providing medical care to these newborns, facilitating the administration of fluids, medications, and blood transfusions. The market is driven by factors such as the incidences of cancer and an aging population adopting unhealthy lifestyles, leading to an increase in new cancer cases and cancer-related deaths. The advancements in technologies like single-cell RNA sequencing and differential gene expression analysis are contributing to the development of umbilical vessel catheters for cancer research. Key players in the market include companies focusing on acquisitions and collaborations to expand their product offerings. For instance, Thermo Fisher Scientific acquired Patheon N.V. to strengthen its position in the pharmaceutical services market. The Journal Experimental Therapeutic Medicine and Therapeutic Medicine have published numerous studies on the use of umbilical vessel catheters in cancer treatment. Umbilical vessel catheters find applications in neonatal care for the treatment of conditions like Hirschsprung disease. Market leaders like Becton, Dickinson and Company, Teleflex Incorporated, and Cook Medical dominate the market, offering a range of umbilical vessel catheters for various applications. The March of Dimes is an organization working towards reducing premature births and improving the health of babies by promoting research, education, and advocacy.
Rising incidence of preterm births is notably driving market growth. Umbilical vessel catheters are essential medical devices used for the administration of fluids, medications, and nutrients to newborns, particularly those born prematurely. The global market for these catheters is witnessing significant growth due to the increasing incidences of preterm births, which account for approximately 15 million babies born each year worldwide. Factors contributing to preterm birth include an interval of less than six months between pregnancies, infections, chronic conditions during delivery, and multiple pregnancies. The aging population and unhealthy lifestyles have led to a rise in new cancer cases and cancer-related deaths, fueling the demand for advanced diagnostic and therapeutic tools in cancer research. Technological advancements in genomics, transcriptomics, proteomics, metabolomics, and mass cytometry have enabled the study of cell interactions and differential gene expression, contributing to a better understanding of tumor development and cellular decline. Umbilical vessel catheters find applications not only in neonatal care but also in research laboratories, hospitals, and biotechnology.
Further, mergers and acquisitions in the industry have led to the development of more sophisticated instruments and consumables, making these catheters increasingly indispensable in fields such as immunology, neurology, stem cell research, non-invasive prenatal diagnosis, and in-vitro fertilization. Despite their high cost, the use of umbilical vessel catheters is essential for the treatment of conditions such as Hirschsprung disease and the care of premature babies, including those with preterm labor, premature rupture of membranes, and premature contractions. Organizations like the March of Dimes are working to reduce preterm births and improve neonatal care, which will further boost the market for umbilical vessel catheters. Thus, such factors are driving the growth of the market during the forecast period.
Advances in umbilical vessel catheters and new products is the key trend in the market. The market is witnessing significant growth due to the introduction of advanced products designed to improve neonatal care. Vendors are focusing on developing innovative solutions to address the challenges of delivering life-saving treatments to premature infants. For instance, Vygon's Surfcath is a specialized umbilical venous catheter that ensures safe and effective delivery of surfactants to premature babies. This catheter's unique design reduces the risk of complications and ensures accurate treatment. Similarly, Cardinal Health's Argyle Umbilical Venous Catheters offer double or triple access using a single lumen catheter, enabling simultaneous therapies to be delivered from one device. This innovation reduces the need for multiple venipunctures and enhances patient comfort. The increasing incidences of cancer, an aging population, and unhealthy lifestyles are leading to new cancer cases and cancer-related deaths. This trend is driving the demand for advanced tools and technologies in cancer research, including genomics, transcriptomics, proteomics, metabolomics, and cell interactions. Mass cytometry and single-cell RNA sequencing are becoming increasingly popular in cancer research for differential gene expression analysis and understanding tumor development and cellular decline.
Moreover, the high cost of consumables and instruments in these fields, along with the need for technological advancement, is leading to mergers and acquisitions among key players in the biotechnology, hospitals, research laboratories, and therapeutic medicine industries. For instance, the March of Dimes and the American Academy of Pediatrics have collaborated to improve newborn health and reduce premature births, preterm birth, and other neonatal health issues. In the field of immunology and neurology, stem cell research is gaining significant attention for its potential in treating various diseases. Non-invasive prenatal diagnosis and in-vitro fertilization are also driving the demand for umbilical vessel catheters in these areas. Overall, the market is expected to grow significantly during the forecast period due to these trends and the continuous technological advancements in the healthcare industry. Thus, such trends will shape the growth of the market during the forecast period.
Lack of skilled nurses and advanced infrastructure in developing countries is the major challenge that affects the growth of the market. Umbilical vessel catheters play a crucial role in delivering essential nutrients and medications to newborns and critically ill patients in neonatal intensive care units (NICUs) and intensive care units (ICUs). However, the proper handling of these catheters is essential to prevent infant discomfort, disruptions in nutrient and medication delivery, and device-related complications. The global market for umbilical vessel catheters is influenced by several factors, including the increasing incidences of cancer, an aging population, and unhealthy lifestyles leading to new cancer cases and cancer-related deaths. Technological advancements in genomics, transcriptomics, proteomics, metabolomics, mass cytometry, single-cell RNA sequencing, and differential gene expression have significantly contributed to cancer research, tumor development, and cellular decline studies. These technologies are increasingly being adopted in research laboratories, hospitals, and biotechnology companies. Despite the high cost of these advanced technologies and consumables, as well as the instruments required for their operation, the market for umbilical vessel catheters is expected to grow due to the increasing demand for non-invasive prenatal diagnosis, in-vitro fertilization, and neonatal care. Premature births and preterm births are also significant drivers of market growth.
However, the lack of trained professionals, especially nurses, in the healthcare industry, particularly in developing countries, poses a challenge to the market's growth. This issue is further compounded by a lack of awareness among healthcare professionals regarding the safety issues associated with umbilical vessel catheters. Umbilical vessel catheters are used in various applications, including cancer research, immunology, neurology, stem cell research, and non-invasive prenatal diagnosis. In cancer research, these catheters are used to study the molecular mechanisms of cancer development and progression, as well as to evaluate the efficacy of new therapies. In immunology and neurology, umbilical vessel catheters are used to study cell interactions and cellular decline. In stem cell research, these catheters are used to deliver nutrients and medications to stem cells, enhancing their growth and differentiation. In non-invasive prenatal diagnosis, umbilical vessel catheters are used to obtain fetal DNA for genetic testing. The market is expected to grow significantly due to the increasing demand for advanced medical technologies in cancer research, stem cell research, and neonatal care. However, the lack of trained professionals and awareness regarding the safety issues associated with these catheters poses a significant challenge to market growth. To address this challenge, there is a need for increased investment in training programs for healthcare professionals and awareness campaigns to promote the safe and effective use of umbilical vessel catheters. Additionally, collaborations and mergers among key players in the market are expected to drive innovation and improve the availability and affordability of these essential medical devices. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Advin Health Care - The company offers umbilical vessel catheters products such as Umbilical Artery Catheter and Umbilical Vein Catheter.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The umbilical artery catheters segment is estimated to witness significant growth during the forecast period. Umbilical vessel catheters play a crucial role in various medical applications, including cancer research, neonatal care, and in-vitro fertilization. With the increasing incidences of cancer due to an aging population and unhealthy lifestyles, the demand for advanced diagnostic tools is surging. Technological advancements in genomics, transcriptomics, proteomics, metabolomics, and mass cytometry are enabling researchers to explore cell interactions and tumor development at a molecular level. Single-cell RNA sequencing and differential gene expression analysis are providing new insights into cancer-related diseases.
Get a glance at the market share of various regions Download the PDF Sample
The umbilical artery catheters segment was the largest and was valued at USD 669.80 million in 2018. The high cost of these consumables and instruments is a significant challenge, but mergers and acquisitions among key players are driving competition and innovation. In cancer research, umbilical vessel catheters are used for non-invasive prenatal diagnosis and Hirschsprung disease diagnosis. In neonatal care, they are used for neonatal intensive care and premature births. In research laboratories and hospitals, umbilical vessel catheters are essential tools in biotechnology, immunology, neurology, and stem cell research. The Journal of Experimental Therapeutic Medicine and Therapeutic Medicine are among the leading publications in this field. Overall, the umbilical vessel catheter market is expected to grow significantly due to the increasing number of new cancer cases and cancer-related deaths.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Umbilical vessel catheters are essential medical devices used in various applications, including neonatal care, in-vitro fertilization, and research laboratories. The market for these catheters is witnessing significant growth due to the increasing incidences of cancer, an aging population, and unhealthy lifestyles leading to new cancer cases and cancer-related deaths. Technological advancements in genomics, transcriptomics, proteomics, metabolomics, and cell interactions are driving research in cancer, immunology, neurology, and stem cell studies. Mass cytometry and single-cell RNA sequencing are key technologies used for differential gene expression analysis and tumor development research. The high cost of these consumables and instruments, along with mergers and acquisitions in the biotechnology industry, are shaping the market landscape.
In addition, non-invasive prenatal diagnosis and neonatal care for premature births and preterm infants, particularly for conditions like Hirschsprung disease, are also contributing to the market growth. The Journal of Experimental Therapeutic Medicine and other reputed publications continue to report on the latest developments and trends in this field.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
You may also interested in below market reports:
The market is witnessing significant growth due to the increasing incidences of cancer and the aging population. Umbilical vessel catheters play a crucial role in cancer research, particularly in the fields of Genomics, Transcriptomics, Proteomics, Metabolomics, and Cell interactions. These techniques help in understanding the differential gene expression and tumor development, leading to new cancer cases and cancer-related deaths. Moreover, technological advancements in mass cytometry and single-cell RNA sequencing have led to the development of non-invasive prenatal diagnosis and in-vitro fertilization techniques. Umbilical vessel catheters are extensively used in research laboratories, hospitals, and biotechnology industries for neonatal care, particularly in premature births and preterm births.
In addition, the market is driven by the high cost of consumables and instruments, mergers and acquisitions, and the increasing demand for minimally invasive procedures. The Journal of Experimental Therapeutic Medicine and Therapeutic Medicine have published numerous studies on the use of umbilical vessel catheters in cancer treatment, immunology, neurology, and stem cell research. Additionally, the market is witnessing growth in the areas of Hirschsprung disease, non-invasive prenatal diagnosis, and in-vitro fertilization. Organizations such as the March of Dimes are also contributing to the market growth by raising awareness and funding for research in neonatal care and umbilical vessel catheter technology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
132 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 10.03% |
|
Market growth 2024-2028 |
USD 852.6 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
8.88 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 36% |
|
Key countries |
US, UK, China, Germany, and Canada |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Advin Health Care, ANGIPLAST Pvt. Ltd., Avanos Medical Inc., B.Braun SE, Cardinal Health Inc., DEVPARV SURGICO, Hangzhou Fushan Medical Appliances Co. Ltd., Insung Medical Co. Ltd., Medtronic Plc, Neotech Products LLC, Poly Medicure Ltd., Ribbel International Ltd., Romsons, Shree Umiya Surgical Pvt. Ltd., Sterimed Medical Devices Pvt. Ltd., Suru International Pvt. Ltd., Teleflex Inc., Utah Medical Products Inc., and Vygon SAS |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period. |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.